Monzr M. Al Malki

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

Javier Bolaños‐Meade, Mehdi Hamadani, Juan Wu et al. · New England Journal of Medicine · 2023 · 460 citations · Full text

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide

Asad Bashey, Mei-Jie Zhang, Shannon R. McCurdy et al. · Journal of Clinical Oncology · 2017 · 321 citations · Full text

Immunology, Biomedical Engineering, Immunotherapy +16

The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results

David A. Sallman, Adam S. Asch, Monzr M. Al Malki et al. · Blood · 2019 · 216 citations

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis

Mahasweta Gooptu, Rizwan Romee, Andrew St. Martin et al. · Blood · 2021 · 157 citations · Full text

Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study

David A. Sallman, Monzr M. Al Malki, Adam S. Asch et al. · Journal of Clinical Oncology · 2023 · 148 citations · Full text